Docoh
Loading...

30 results

Filter options loading...
Top filers
Top filing types
Recent filing years
10-Q
2021 Q2
PCSA Processa Pharmaceuticals Inc
12 Aug 21
Quarterly report
4:01pm
the globe have responded with fiscal policy actions to support the healthcare industries and economies as a whole. Whether this support continues
10-Q
2021 Q1
PCSA Processa Pharmaceuticals Inc
13 May 21
Quarterly report
4:30pm
negatively affect our liquidity. Policymakers around the globe have responded with fiscal policy actions to support the healthcare industries
DEF 14A
PCSA Processa Pharmaceuticals Inc
22 Apr 21
Definitive proxy
2:00pm
and DKBK Enterprises, LLC CorLyst owns 7.3% of our common stock. We share certain administrative expenses with CorLyst (salaries, healthcare and office
10-K/A
2020 FY
PCSA Processa Pharmaceuticals Inc
7 Apr 21
Annual report (amended)
4:23pm
administrative expenses with CorLyst (salaries, healthcare and office space). David Young, our CEO and Chairman of our Board of Directors, is also the CEO
10-K
2020 FY
PCSA Processa Pharmaceuticals Inc
24 Mar 21
Annual report
8:00pm
, Dear Healthcare Provider letters, press releases or other communications containing warning or other safety information about the product; fines … healthcare regulation and enforcement by the federal government and by authorities in the states and foreign jurisdictions in which they conduct
10-Q
9fx29 nod
12 Nov 20
Quarterly report
4:01pm
424B4
7i70xhwco inl8zgsc
5 Oct 20
Prospectus supplement with pricing info
4:16pm
S-1/A
ukcc0s9zmx86 1dv9k
30 Sep 20
IPO registration (amended)
4:06pm
S-1/A
xvk5qlw1rasd8fa
16 Sep 20
IPO registration (amended)
8:00pm
8-K
EX-99.1
afu3 s2vwkpeue3eflvu
20 Aug 20
Entry into a Material Definitive Agreement
9:30am
S-1/A
pakukxc
17 Jul 20
IPO registration (amended)
5:25pm
10-K
20jz02dy431kz 1me
5 Mar 20
Annual report
7:00pm
8-K
EX-99.1
cvg012wgqof2n3x6zh7b
5 Mar 20
Processa Pharmaceuticals Announces Formation of Its Medical and Scientific Advisory Board
9:30am
S-1
zz1ky6h3ou0skxwx
13 Dec 19
IPO registration
5:32pm
DEF 14A
eilvhl3 izgy9g
26 Apr 19
Definitive proxy
5:02pm
10-K/A
om0utz8dw
5 Apr 19
Annual report (amended)
9:40pm
10-K
ag0y0
28 Mar 19
Annual report
5:25pm
424B3
qqas8xp
9 Nov 18
Prospectus supplement
5:04pm
S-1/A
xwpuavnptmq6zxl178x
30 Oct 18
IPO registration (amended)
4:19pm
CORRESP
yn72p8pfax ury
29 Oct 18
Correspondence with SEC
8:00pm